Visualizations Notes: This visualization displays fee-for-service (FFS) retail pharmaceutical costs (billed on a pharmacy claim) paid by an insurance plan only
Eriss liraglutide, an older off-patent GLP-1, does about 1 crore a month
Semaglutide helps lower blood sugar in a glucose-dependent way, which means it works more when blood sugar is elevated and less when it is normal
On the other hand, the two-pack bundle not only reduces the per-bottle cost but also ensures a consistent supply for at least two months, which is often the recommended duration for achieving significant results
5.3 The Biosimilar Case Study: Humira and What Happened Next The adalimumab (Humira) biosimilar market provides a more complicated and commercially instructive case
When GLP-1 medications slow intestinal transit, your colon has more time to absorb water from stool